Review article: the control of gastric acid and Helicobacter pylori eradication. - Wikidata - wikimedia - TriplyDB

Review article: the control of gastric acid and Helicobacter pylori eradication.

Review article: the control of gastric acid and Helicobacter pylori eradication.

http://www.wikidata.org/entity/Q34078518

about

The gastric H,K ATPase as a drug target: past, present, and future Comparison of five-day Helicobacter pylori eradication regimens: rabeprazole-based and omeprazole-based regimens with and without omeprazole pretreatment H+/K+-ATPase inhibitors: a patent review.Update on the management of Helicobacter pylori infection, including drug-resistant organisms.Management of laryngopharyngeal reflux with proton pump inhibitors.Review of rabeprazole in the treatment of gastro-oesophageal reflux disease.H. pylori infection: bacterial virulence factors and cytokine gene polymorphisms as determinants of infection outcome.Review article: the pharmacodynamics and pharmacokinetics of proton pump inhibitors--overview and clinical implications.Review article: relief of symptoms in gastric acid-related diseases--correlation with acid suppression in rabeprazole treatment.Novel effects other than antisecretory action and off-label use of proton pump inhibitors.Influence of pretreatment with H2 receptor antagonists on the cure rates of Helicobacter pylori eradication.Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.Vonoprazan 20 mg vs lansoprazole 30 mg for endoscopic submucosal dissection-induced gastric ulcers.Comparative study: Vonoprazan and proton pump inhibitors in Helicobacter pylori eradication therapy.The difficult patient: drug interaction and the influence of concomitant diseases on the treatment of hypothyroidism.Role of bismuth in improving Helicobacter pylori eradication with triple therapy.Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects.Tablet and oral liquid L-thyroxine formulation in the treatment of naïve hypothyroid patients with Helicobacter pylori infection.Helicobacter pylori Eradication with Proton Pump Inhibitors or Potassium-Competitive Acid Blockers: The Effect of Clarithromycin Resistance.Mechanisms of increased acid secretion after eradication of Helicobacter pylori infection.A new furoxan NO-donor rabeprazole derivative and related compounds.Stomach myoelectrical response of patients with gastroesophageal reflux disease receiving omeprazole treatment.Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases.Comparison of oral and intravenous lansoprazole for the prevention of bleeding from artificial ulcers after endoscopic submucosal dissection for gastric tumors: a prospective randomized phase II study (KDOG 0802).Negative Effect of Proton-pump Inhibitors (PPIs) on Helicobacter pylori Growth, Morphology, and Urease Test and Recovery after PPI Removal--An In vitro Study.

P2860

Q24631084-DF0C2E36-31E6-4037-A3B7-DD2C0F8B6F71 Q33739015-0B6E30D9-F5E1-4052-AD08-DFA087FFD137 Q34315036-A76B0D1B-82E2-43FA-BA96-CCA861A82A06 Q34619427-4BFFE7DB-09E3-433C-8D6B-7A7DEF1E9F20 Q34814157-DBC75668-58B4-4823-83E7-1174959C20AA Q35609697-624E5FFD-38E1-4CA9-A965-CE1A51ABD3B4 Q35861502-5936ED96-97F3-4800-8391-9FFC229CBAC8 Q35923949-B9BF3208-C264-424B-AEB5-676A0D13A0E1 Q35923959-395D8C8A-A059-4B3A-B994-6E82FE9A918F Q36040679-525024B0-ADCE-4A58-9B77-B2D26B96E4A1 Q36516636-B79C9077-5B8C-4272-8C73-68BB69838455 Q37345977-8708ABCE-1272-45CA-8C30-8FA72A662449 Q37421468-6B6FD74D-F647-4F9D-A167-0BC79757CABD Q37625226-8AF2B764-020F-4535-96B6-524E2FFC6588 Q37778756-43BE8F3D-1E2B-4EF9-A644-F8B2C69F109D Q38723877-D18EB9FA-89E4-45A5-A30B-43E59C272DB2 Q39746768-0CADE46F-3B57-4813-8D66-1DA9930292BD Q40450159-305FB1CB-873E-41EC-B6F8-D891B74A86D5 Q40502852-E1C67A40-4181-41F1-9217-FF034A233928 Q41864070-7C6F9435-36EA-449D-802C-423898B8D078 Q44578589-0613C24C-39FA-4835-87A3-7026EFBBD155 Q44693187-52CD8C14-8C80-450F-B9E5-C8F6D2D6550E Q48339888-399BF0DA-E00E-4ABA-8B5E-277B343C61B8 Q49605370-F623775B-E843-423D-9F02-563BAA664C43 Q53402835-FEF8542C-3C7F-4BDE-817B-B3936703F392

P2860

Review article: the control of gastric acid and Helicobacter pylori eradication.

http://www.wikidata.org/entity/Q34078518

description

2000 nî lūn-bûn

@nan

2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年学术文章

@wuu

2000年学术文章

@zh-cn

2000年学术文章

@zh-hans

2000年学术文章

@zh-my

2000年学术文章

@zh-sg

2000年學術文章

@yue

name

Review article: the control of gastric acid and Helicobacter pylori eradication.

@ast

Review article: the control of gastric acid and Helicobacter pylori eradication.

@en

Review article: the control of gastric acid and Helicobacter pylori eradication.

@nl

type

label

Review article: the control of gastric acid and Helicobacter pylori eradication.

@ast

Review article: the control of gastric acid and Helicobacter pylori eradication.

@en

Review article: the control of gastric acid and Helicobacter pylori eradication.

@nl

prefLabel

Review article: the control of gastric acid and Helicobacter pylori eradication.

@ast

Review article: the control of gastric acid and Helicobacter pylori eradication.

@en

Review article: the control of gastric acid and Helicobacter pylori eradication.

@nl

P1433

Q34078518-F0FF9D81-63F6-4714-8767-079E7AF69C6A

P1476

Q34078518-185155C8-E643-475A-BC45-23B8427A2E13

P2093

Q34078518-323A725A-B85C-4C3D-8860-1FBB300E9B0C

Q34078518-7024F910-2647-4919-B61D-BAAF30AC89BC

Q34078518-7A70C2E5-8B3B-4D6A-9ED7-D8CEFBB3CF24

Q34078518-8CAD911A-ED32-4B07-AD1A-6D2FC4B79F00

Q34078518-95C06639-8BCC-4A68-865C-9F155DAAA985

Q34078518-E9ADDBA9-5C59-447B-8426-61C6D6FA5082

Q34078518-F9B6B063-D593-4F04-BD23-340EE6BFC18A

P2860

Q34078518-04D56F45-5E5C-473C-93E4-1FD90C4B2529

Q34078518-116C6064-7657-4233-8741-A4025512D838

Q34078518-1986F932-FDB3-465F-812A-E9A10BD40248

Q34078518-224D2F50-E50B-419E-A7C8-48A6CC6D20D6

Q34078518-249E3740-36E1-45F7-935C-D60A915A980E

Q34078518-2D4DA9A3-CAAB-405B-85AF-656EFE12B3D5

Q34078518-3C4DBC0E-14AF-4BD1-A6A3-58B3641F18A6

Q34078518-5C3ADCF0-99B2-4BED-8A47-96D900A66AA0

Q34078518-74396665-9B55-422C-8FFA-E6AE46DF7FEF

Q34078518-7766EAC0-6B0B-4561-9A47-57DEF16838CF

P304

Q34078518-11CBCAA8-B1C6-400E-823D-8F2D800FCF93

P31

Q34078518-7E0AAC97-D2C2-4671-84F7-9AE6326D7A9B

P356

Q34078518-C6240C25-B5BC-46AF-A021-4A76639DD168

P407

Q34078518-773600CF-44F9-48F3-9619-9B13533B062D

P433

Q34078518-55AEAE75-3D8F-4205-BB74-25E4844C68D3

P478

Q34078518-F1C942AD-DA09-4DE7-BB84-F58A7DE8B2E3

P50

Q34078518-5FB71B7C-A5C4-44AF-8512-F2B3A59A3733

P577

Q34078518-0767EEAB-6DAB-413B-942C-A0F7E5655065

P5875

Q34078518-45847BC1-1658-4D34-9009-FA3DDF867EAB

P698

Q34078518-A10D7B1D-FABF-42D5-ACB1-1F39A184B4A3

P921

Q34078518-8E8A8E62-D481-40E0-A345-226B54288A25

P356

J.1365-2036.2000.00837.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Review article: the control of gastric acid and Helicobacter pylori eradication

@en

P2093

D L Weeks

http://www.w3.org/2001/XMLSchema#string

D R Scott

http://www.w3.org/2001/XMLSchema#string

G Sachs

http://www.w3.org/2001/XMLSchema#string

J M Shin

http://www.w3.org/2001/XMLSchema#string

K Melchers

http://www.w3.org/2001/XMLSchema#string

K Munson

http://www.w3.org/2001/XMLSchema#string

O Vagin

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of a beta subunit of the gastric H+/K(+)-transporting ATPase

Unidentified curved bacilli on gastric epithelium in active chronic gastritis

Changes of protein structure, nucleotide microenvironment, and Ca(2+)-binding states in the catalytic cycle of sarcoplasmic reticulum Ca(2+)-ATPase: investigation of nucleotide binding, phosphorylation and phosphoenzyme conversion by FTIR difference

Three-dimensional map of the plasma membrane H+-ATPase in the open conformation.

Helicobacter pylori virulence and genetic geography.

Dynamic regulation of gastric surface pH by luminal pH

ATP-Induced phosphorylation of the sarcoplasmic reticulum Ca2+ ATPase: molecular interpretation of infrared difference spectra

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase.

The role of Helicobacter pylori urease in the pathogenesis of gastritis and peptic ulceration.

cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors

P304

1383-1401

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2000.00837.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

245664801

http://www.w3.org/2001/XMLSchema#string

P698

11069309

http://www.w3.org/2001/XMLSchema#string

P921

Helicobacter pylori